Your Finances or a Facelift? It's Time to Downsize
Leading Image Enhancement Coach Wendy Lewis Explains the New Face of Frugality NEW YORK, Feb. 11 /PRNewswire/ -- International beauty expert and leading image enhancement coach Wendy Lewis, counsels private clients on all aspects of cosmetic enhancements and anti-aging beauty treatments from ...NJHA: Hospital Finances Show Troubling Trends
Report Says 2007 Total Margins Shrunk; Nearly Half Lost Money PRINCETON, N.J., Nov. 25 /PRNewswire-USNewswire/ -- Nearly half of the state's hospitals - 47 percent - posted overall losses at the end of 2007, according to new audited financial data contained in the 2008 edition of the New ...SEIU Sending Team to Review Finances at Local 6434, United Long Term Care Workers Union
LOS ANGELES, Aug. 10 /PRNewswire-USNewswire/ -- The Service Employees International Union will send a review team to Los Angeles this week to investigate allegations concerning the financial practices at Local 6434, United Long Term Care Workers Union. The review team will come to Los Angeles ...Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances
MARYVILLE, Ill., Aug. 3 /PRNewswire/ -- In the midst of bad economic times, Anderson Hospital's Surgery Center is thriving, thanks to the devoted efforts of hospital staff and the assistance of a healthcare consulting firm out of Elm Grove, Wisconsin, Compirion Healthcare Solutio...NHS duped by Foreigners? IVF treatments Drain NHS Finances
New figures have established the magnitude of financial drain on the NHS; Foreigners, have milked the NHS by availing treatments// in UK hospitals worth millions of pounds, for which they have not paid for. The ones who have played truant are mostly couples availing IVF treatment and have vanished ...NHS To Pay More Attention To Its Finances
The Health Secretary of the UK Patricia Hewitt, will call for better financial management of clinical objectives, and also call for a halt to the existing handout culture.// As per the new system that she is calling for, the survival of the health trusts will depend upon their capacity to attract p...Neurocrine Biosciences Presents Elagolix Data
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and Company overall. Specifically, the risks and uncertainti...GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
...er of the vaccine and Senior V.P. of Research and Development at GeoVax. "This network provides a wide array of support for its clinical trials, from finances to statistical design and analysis; from community engagement to rigorous laboratory analysis. Working with the HVTN also affords us the input of the ...Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and Company overall. Specifically, the risks and uncertainti...Neurocrine Biosciences Completes 'Petal Study' Treatment Phase for Endometriosis
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and R & D pipeline and Company overall. Specifically, the ri...Neurocrine Biosciences Reports First Quarter 2008 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and R & D pipeline and Company overall. Specifically, the ri...DermaGen AB Receives Over 1 Million Euros From a New Share Issue
...ent. In January 2007, the endowment's market value was approximately 7.1 billion Swedish kronor. There are two committees of the Board, one deals with finances and one for academic affairs. The Foundation is governed by a Board appointed by the Swedish government. For further information please contact: ...Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's indiplon program, GnRH program, R & D pipeline and Company overall. Speci...Patient Navigators Help Minority, Low-Income Cancer Patients Get Life-Saving Treatments
... getting cancer treatment. Lack of transportation to healthcare providers was cited as the greatest obstacle in getting quality care, while inadequate finances to pay for medical care was also a significant challenge among these patients. For more information on radiation therapy, visit http://www.rtanswers...GenoMed Prevents Sickle Cell Pain for Over a Year
...fe Harbor Statement This press release contains forward-looking statements, including those statements pertaining to GenoMed, Inc.'s (the Company's) finances and treatments. The words or phrases "ought to," "should," "could," "may," or similar expressions are intended to identify "forward-looking statements...DAQbilling Medical Billing System
Description:...run on any computer from anywhere - multiples offices or home. With this combination of software and service, you retain control over your practices finances while DAQbilling performs all of your billing tasks....Double success for Instituto Gulbenkian de Ciencia scientists working on chromosome segregation
...come to full fruition." Portugal is a member state participating in the EMBC, the EMBO intergovernmental funding body and, as such, hosts and fully finances the grants awarded to scientists who wish to establish themselves in this country. This award will be jointly financed by the Portuguese government fu...Neurocrine Biosciences Reports Second Quarter 2009 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program, R & D pipeline and Company overall. Specifically, the r...Neurocrine Biosciences Reports First Quarter 2009 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program, R & D pipeline and Company overall. Specifically, th...Neurocrine Announces Work Force Restructuring
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general and the other risks described in the Company's report on Form 10-K for the year ended December 31, 2008. Neurocrine undertakes no obligati...Helping Young Women Succeed in Today's Unpredictable World
...17 /PRNewswire/ -- Many young women enter the "real world" expecting that life will go according to plan, particularly when it comes to their careers, finances and relationships. Unfortunately, the reality is that the unexpected often happens -- a looming problem especially in today's challenging economic en...Neurocrine Biosciences Reports Third Quarter 2008 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's R & D pipeline and Company overall. Specifically, the risks and uncertain...Neurocrine Biosciences Reports Second Quarter 2008 Results
...ults to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's R & D pipeline and Company overall. Specifically, the risks and uncertain...